[go: up one dir, main page]

BRPI0900802B8 - pharmaceutical and/or cosmetic formulations containing essential oils and compounds isolated from extracts of baccharis spp. - Google Patents

pharmaceutical and/or cosmetic formulations containing essential oils and compounds isolated from extracts of baccharis spp.

Info

Publication number
BRPI0900802B8
BRPI0900802B8 BRPI0900802A BRPI0900802A BRPI0900802B8 BR PI0900802 B8 BRPI0900802 B8 BR PI0900802B8 BR PI0900802 A BRPI0900802 A BR PI0900802A BR PI0900802 A BRPI0900802 A BR PI0900802A BR PI0900802 B8 BRPI0900802 B8 BR PI0900802B8
Authority
BR
Brazil
Prior art keywords
extracts
pharmaceutical
essential oils
cosmetic formulations
baccharis
Prior art date
Application number
BRPI0900802A
Other languages
Portuguese (pt)
Inventor
Cristina Morseli Polizello Ana
César Cropanese Spadaro Augusto
Pimenta Da Silva Leitão Denise
Kenupp Bastos Jairo
Freire Leite Mateus
Fonseca Vianna Lopez Renata
Original Assignee
Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp
Univ Sao Paulo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp, Univ Sao Paulo filed Critical Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp
Priority to BRPI0900802A priority Critical patent/BRPI0900802B8/en
Publication of BRPI0900802A2 publication Critical patent/BRPI0900802A2/en
Publication of BRPI0900802B1 publication Critical patent/BRPI0900802B1/en
Publication of BRPI0900802B8 publication Critical patent/BRPI0900802B8/en

Links

Landscapes

  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

óleos essenciais e compostos isolados de extratos de baccharis spp., formulações farmacêuticas e/ou cosméticas e seus usos a presente invenção refere-se a óleos essenciais e/ou compostos isolados de extratos de baccharis spp., preferencialmente, baccharis dracunculifolia d.c. adicionalmente o presente pedido provê formulações farmacêuticas e/ou cosméticas, preferencialmente, microemulsões contendo o dito óleo essencial e/ou compostos isolados aplicados como agentes analgésicos, antiinflamatórios, cicatrizantes, antibacteriano, anticariogênico e/ou antineoplásicos,preferencialmente, como agentes para saúde bucal.essential oils and compounds isolated from extracts of baccharis spp., pharmaceutical and/or cosmetic formulations and their uses the present invention relates to essential oils and/or compounds isolated from extracts of baccharis spp., preferably, baccharis dracunculifolia d.c. additionally, the present application provides pharmaceutical and/or cosmetic formulations, preferably microemulsions containing said essential oil and/or isolated compounds applied as analgesic, anti-inflammatory, healing, antibacterial, anticariogenic and/or antineoplastic agents, preferably as agents for oral health.

BRPI0900802A 2009-03-12 2009-03-12 pharmaceutical and/or cosmetic formulations containing essential oils and compounds isolated from extracts of baccharis spp. BRPI0900802B8 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI0900802A BRPI0900802B8 (en) 2009-03-12 2009-03-12 pharmaceutical and/or cosmetic formulations containing essential oils and compounds isolated from extracts of baccharis spp.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0900802A BRPI0900802B8 (en) 2009-03-12 2009-03-12 pharmaceutical and/or cosmetic formulations containing essential oils and compounds isolated from extracts of baccharis spp.

Publications (3)

Publication Number Publication Date
BRPI0900802A2 BRPI0900802A2 (en) 2010-11-09
BRPI0900802B1 BRPI0900802B1 (en) 2020-03-24
BRPI0900802B8 true BRPI0900802B8 (en) 2021-05-25

Family

ID=43064045

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0900802A BRPI0900802B8 (en) 2009-03-12 2009-03-12 pharmaceutical and/or cosmetic formulations containing essential oils and compounds isolated from extracts of baccharis spp.

Country Status (1)

Country Link
BR (1) BRPI0900802B8 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022082277A1 (en) * 2020-10-19 2022-04-28 BATOCCHIO, Ana Lúcia Torrez Propolis-based natural composition and preparation method
US11998572B2 (en) 2021-06-29 2024-06-04 Imam Abdulrahman Bin Faisal University Method for treating nociceptive pain and burns with brazilian green propolis alcohol extract

Also Published As

Publication number Publication date
BRPI0900802B1 (en) 2020-03-24
BRPI0900802A2 (en) 2010-11-09

Similar Documents

Publication Publication Date Title
PA8780201A1 (en) PIRASOL DERIVATIVES REPLACED WITH HETEROARIL USEFUL TO TREAT HYPERPROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS
BR112013015855A2 (en) compound, use of a compound, methods of prevention, treatment, amelioration or prophylaxis of physiological disorders or diseases, and treatment or amelioration of cosmetic indications; and, pharmaceutical composition.
BR112013015859A2 (en) compound, use of a compound, methods of prevention, treatment, amelioration or prophylaxis of physiological disorders or diseases, and treatment or amelioration of cosmetic indications, and, pharmaceutical composition
CO6690805A2 (en) 6-amino-nicotinamides substituted as modular of kcnq2 / 3
MX2011008171A (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES LINAGLIPTINA AND OPTIONALLY A SGLT2 INHIBITOR, AND USES OF THE SAME.
BR112013004766A2 (en) Substituted 2-amino-quinoline-3-carboxamides as kcnq2 / 3 modulators
WO2008116912A3 (en) Purinyl derivatives and their use as potassium channel modulators
DOP2011000218A (en) SULFONAMIDE DERIVATIVES
CL2012001605A1 (en) Quinoline-2-carboxamide derived compounds, positive allosteric modulators of the muscarine m1 receptor; pharmaceutical composition comprising the compound; and its use in the preparation of drugs for the treatment of diseases such as Alzheimer's, pain or sleep disorders.
BR112015015468B8 (en) COMPOUND AND PHARMACEUTICAL COMPOSITION
EP2402341A3 (en) Purinyl derivatives and their use as potassium channel modulators
CA2863413A1 (en) Substituted prolines / piperidines as orexin receptor antagonists
BRPI1014902A2 (en) p2x7r antagonist compound, its composition and its uses
BRPI0916069A2 (en) "compound, uses of a compound, pharmaceutical composition, cosmetic composition and cosmetic uses of a composition"
BR112013015877A2 (en) compound, use of a compound, prevention methods. treatment, amelioration or prophylaxis of physiological disorders or diseases, and treatment or amelioration of cosmetic indications, and, pharmaceutical composition.
MX336452B (en) Skin clarifying complex, use of said complex, cosmestic or pharmaceutical composition comprising said complex and method for application thereof.
EA201200616A1 (en) DERIVATIVES 2-OXO-1-PIRROLIDININILIMIDAZOTHIAADIA ASOL
BR112015004306A2 (en) fluoromethyl-substituted pyrrol carboxamides
UY32744A (en) DERIVATIVES OF 2-CARBOXAMIDA-7-PIPERAZINIL-BENZOFURANO 774
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
ECSP13012453A (en) 2-oxy-quinoline-3-carboxamides substituted as KCNQ2 / 3 modulators
CL2010001174A1 (en) Use of spironolactone, its polymorphs, hydrates or solvates to prepare a useful medication to prevent and / or treat muiltiple sclerosis.
BR112012024586A2 (en) purine compounds
CR11665A (en) DUE PHARMACOPHORIS-MUSCARINIC ANTAGONISTS OF PDE4
TR201004464A2 (en) Formulation for bone resorption.

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B15V Prolongation of time limit allowed
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 24/03/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/03/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF